February 28, 2023
An estimated 32,270 people have received Shionogi’s oral COVID-19 treatment Xocova (ensitrelvir) between the start of its distribution in Japan on November 24 and February 19, according to the company’s latest update. According to the sixth Xocova post-marketing surveillance update,...read more